Nicotine withdrawal

I McLaughlin, JA Dani, M De Biasi - The Neuropharmacology of Nicotine …, 2015 - Springer
An aversive abstinence syndrome manifests 4–24 h following cessation of chronic use of
nicotine-containing products. Symptoms peak on approximately the 3rd day and taper off …

Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment

RL Ashare, M Falcone, C Lerman - Neuropharmacology, 2014 - Elsevier
Nicotine withdrawal is associated with deficits in neurocognitive function including sustained
attention, working memory, and response inhibition. Several convergent lines of evidence …

Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease

B Ritz, PC Lee, CF Lassen, OA Arah - Neurology, 2014 - AAN Enterprises
Objective: To assess whether being able to quit smoking is an early marker of Parkinson
disease (PD) onset rather than tobacco being “neuroprotective,” we analyzed information …

Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study

DW Belsky, TE Moffitt, TB Baker, AK Biddle… - JAMA …, 2013 - jamanetwork.com
Importance Genome-wide hypothesis-free discovery methods have identified loci that are
associated with heavy smoking in adulthood. Research is needed to understand …

Molecular genetics of successful smoking cessation: convergent genome-wide association study results

GR Uhl, QR Liu, T Drgon, C Johnson… - Archives of general …, 2008 - jamanetwork.com
Context Smoking remains a major public health problem. Twin studies indicate that the
ability to quit smoking is substantially heritable, with genetics that overlap modestly with the …

ADHD and smoking: from genes to brain to behavior

FJ McClernon, SH Kollins - Annals of the New York Academy of …, 2008 - Wiley Online Library
Attention‐deficit/hyperactivity disorder (ADHD) and tobacco smoking are among the most
common and costly psychiatric and behavioral problems. The rates of co‐occurrence of …

Smokescreen: a targeted genotyping array for addiction research

JW Baurley, CK Edlund, CI Pardamean, DV Conti… - BMC genomics, 2016 - Springer
Background Addictive disorders are a class of chronic, relapsing mental disorders that are
responsible for increased risk of mental and medical disorders and represent the largest …

Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials

DP King, S Paciga, E Pickering, NL Benowitz… - …, 2012 - nature.com
Despite effective therapies for smoking cessation, most smokers find quitting difficult and
most successful quitters relapse. Considerable evidence supports a genetic risk for nicotine …

Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs

GR Uhl, QR Liu, T Drgon, C Johnson, D Walther… - BMC genetics, 2007 - Springer
Background Classical genetic studies indicate that nicotine dependence is a substantially
heritable complex disorder. Genetic vulnerabilities to nicotine dependence largely overlap …

The dopamine transporter role in psychiatric phenotypes

A Salatino‐Oliveira, LA Rohde… - American Journal of …, 2018 - Wiley Online Library
The dopamine transporter (DAT) is one of the most relevant and investigated
neurotransmitter transporters. DAT is a plasma membrane protein which plays a …